1
|
SSEA-1 is an enrichment marker for tumor-initiating cells in human glioblastoma.
|
Cell Stem Cell
|
2009
|
3.89
|
2
|
Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas.
|
Lab Invest
|
2008
|
2.79
|
3
|
Phosphorylation of EZH2 activates STAT3 signaling via STAT3 methylation and promotes tumorigenicity of glioblastoma stem-like cells.
|
Cancer Cell
|
2013
|
2.38
|
4
|
The efficacy of fractionated radiotherapy and stereotactic radiosurgery for pituitary adenomas: long-term results of 125 consecutive patients treated in a single institution.
|
Cancer
|
2007
|
2.28
|
5
|
Development of a T1 contrast agent for magnetic resonance imaging using MnO nanoparticles.
|
Angew Chem Int Ed Engl
|
2007
|
2.19
|
6
|
Leptomeningeal carcinomatosis in non-small-cell lung cancer patients: impact on survival and correlated prognostic factors.
|
J Thorac Oncol
|
2013
|
1.93
|
7
|
Prognostic significance of c-Met expression in glioblastomas.
|
Cancer
|
2009
|
1.68
|
8
|
Relationship between malignant subtypes of meningioma and clinical outcome.
|
J Clin Neurosci
|
2007
|
1.58
|
9
|
Atypical spontaneous intracranial hypotension (SIH) with nonorthostatic headache.
|
Headache
|
2007
|
1.58
|
10
|
Double antiangiogenic protein, DAAP, targeting VEGF-A and angiopoietins in tumor angiogenesis, metastasis, and vascular leakage.
|
Cancer Cell
|
2010
|
1.47
|
11
|
Patient-specific orthotopic glioblastoma xenograft models recapitulate the histopathology and biology of human glioblastomas in situ.
|
Cell Rep
|
2013
|
1.44
|
12
|
Inhibitor of differentiation 4 drives brain tumor-initiating cell genesis through cyclin E and notch signaling.
|
Genes Dev
|
2008
|
1.34
|
13
|
Frizzled 4 regulates stemness and invasiveness of migrating glioma cells established by serial intracranial transplantation.
|
Cancer Res
|
2011
|
1.30
|
14
|
MET signaling regulates glioblastoma stem cells.
|
Cancer Res
|
2012
|
1.29
|
15
|
EGFR-AKT-Smad signaling promotes formation of glioma stem-like cells and tumor angiogenesis by ID3-driven cytokine induction.
|
Cancer Res
|
2011
|
1.25
|
16
|
CXCR4 signaling regulates metastasis of chemoresistant melanoma cells by a lymphatic metastatic niche.
|
Cancer Res
|
2010
|
1.24
|
17
|
Wnt activation is implicated in glioblastoma radioresistance.
|
Lab Invest
|
2011
|
1.22
|
18
|
Metronomic treatment of temozolomide inhibits tumor cell growth through reduction of angiogenesis and augmentation of apoptosis in orthotopic models of gliomas.
|
Oncol Rep
|
2006
|
1.15
|
19
|
A pilot study of metronomic temozolomide treatment in patients with recurrent temozolomide-refractory glioblastoma.
|
Oncol Rep
|
2006
|
1.15
|
20
|
Dual inhibition of epidermal growth factor receptor and vascular endothelial growth factor receptor phosphorylation by AEE788 reduces growth and metastasis of human colon carcinoma in an orthotopic nude mouse model.
|
Cancer Res
|
2005
|
1.13
|
21
|
Phase II trial of low-dose continuous (metronomic) treatment of temozolomide for recurrent glioblastoma.
|
Neuro Oncol
|
2010
|
1.11
|
22
|
Efficacy of stereotactic radiosurgery as a salvage treatment for recurrent malignant gliomas.
|
Cancer
|
2008
|
1.11
|
23
|
Clinical outcome of concomitant chemoradiotherapy followed by adjuvant temozolomide therapy for glioblastaomas: single-center experience.
|
Clin Neurol Neurosurg
|
2009
|
1.10
|
24
|
Splicing variant of AIMP2 as an effective target against chemoresistant ovarian cancer.
|
J Mol Cell Biol
|
2012
|
1.10
|
25
|
Wnt/β-catenin signaling is a key downstream mediator of MET signaling in glioblastoma stem cells.
|
Neuro Oncol
|
2012
|
1.09
|
26
|
Cancer-Specific requirement for BUB1B/BUBR1 in human brain tumor isolates and genetically transformed cells.
|
Cancer Discov
|
2012
|
1.07
|
27
|
Genomic profiling combined with gene expression profiling in primary central nervous system lymphoma.
|
Blood
|
2010
|
1.06
|
28
|
Inhibition of platelet-derived growth factor receptor signaling restricts the growth of human breast cancer in the bone of nude mice.
|
Clin Cancer Res
|
2005
|
1.05
|
29
|
Combination celecoxib and temozolomide in C6 rat glioma orthotopic model.
|
Oncol Rep
|
2006
|
1.00
|
30
|
Genetically engineered human neural stem cells with rabbit carboxyl esterase can target brain metastasis from breast cancer.
|
Cancer Lett
|
2011
|
0.99
|
31
|
The neural stem cell fate determinant TLX promotes tumorigenesis and genesis of cells resembling glioma stem cells.
|
Mol Cells
|
2010
|
0.97
|
32
|
Negative regulation of p53 by the long isoform of ErbB3 binding protein Ebp1 in brain tumors.
|
Cancer Res
|
2010
|
0.96
|
33
|
Therapeutic effects of human adipose stem cell-conditioned medium on stroke.
|
J Neurosci Res
|
2012
|
0.96
|
34
|
Clinical outcomes of tuberculum sellae meningiomas focusing on reversibility of postoperative visual function.
|
Acta Neurochir (Wien)
|
2012
|
0.95
|
35
|
Induction of apoptosis in tumor-associated endothelial cells and therapy of orthotopic human pancreatic carcinoma in nude mice.
|
Neoplasia
|
2005
|
0.95
|
36
|
High-throughput screening (HTS) of anticancer drug efficacy on a micropillar/microwell chip platform.
|
Anal Chem
|
2013
|
0.94
|
37
|
Interferon regulatory factor 7 regulates glioma stem cells via interleukin-6 and Notch signalling.
|
Brain
|
2012
|
0.94
|
38
|
Genomic copy number alterations associated with the early brain metastasis of non-small cell lung cancer.
|
Int J Oncol
|
2012
|
0.93
|
39
|
Treatment outcomes of pediatric craniopharyngioma : a 15-year retrospective review of 35 cases.
|
J Korean Neurosurg Soc
|
2012
|
0.93
|
40
|
Alpha-smooth muscle actin (ACTA2) is required for metastatic potential of human lung adenocarcinoma.
|
Clin Cancer Res
|
2013
|
0.93
|
41
|
Human neural stem cells can target and deliver therapeutic genes to breast cancer brain metastases.
|
Mol Ther
|
2009
|
0.92
|
42
|
MicroRNA-146a suppresses metastatic activity in brain metastasis.
|
Mol Cells
|
2012
|
0.92
|
43
|
Identification of a peptide that interacts with Nestin protein expressed in brain cancer stem cells.
|
Biomaterials
|
2011
|
0.91
|
44
|
Treatment of atypical meningioma.
|
J Clin Neurosci
|
2010
|
0.90
|
45
|
Trans-differentiation of neural stem cells: a therapeutic mechanism against the radiation induced brain damage.
|
PLoS One
|
2012
|
0.90
|
46
|
In vivo specific delivery of c-Met siRNA to glioblastoma using cationic solid lipid nanoparticles.
|
Bioconjug Chem
|
2011
|
0.90
|
47
|
Combination treatment with temozolomide and thalidomide inhibits tumor growth and angiogenesis in an orthotopic glioma model.
|
Int J Oncol
|
2006
|
0.89
|
48
|
Telomerase activity-independent function of TERT allows glioma cells to attain cancer stem cell characteristics by inducing EGFR expression.
|
Mol Cells
|
2010
|
0.89
|
49
|
Gamma knife surgery for brain metastases in patients harboring four or more lesions: survival and prognostic factors.
|
J Neurosurg
|
2005
|
0.89
|
50
|
Challenging reconstructive techniques for skull base defect following endoscopic endonasal approaches.
|
Acta Neurochir (Wien)
|
2011
|
0.89
|
51
|
Erlotinib prevents pulmonary metastasis in curatively resected breast carcinoma using a mouse model.
|
Oncol Rep
|
2006
|
0.88
|
52
|
Gamma knife radiosurgery for ten or more brain metastases.
|
J Korean Neurosurg Soc
|
2008
|
0.88
|
53
|
A new anti-c-Met antibody selected by a mechanism-based dual-screening method: therapeutic potential in cancer.
|
Mol Cells
|
2012
|
0.88
|
54
|
Endoscopic optic canal decompression for compressive optic neuropathy.
|
J Clin Neurosci
|
2011
|
0.87
|
55
|
Outcome of repeated radiosurgery for recurrent metastatic brain tumors.
|
Clin Neurol Neurosurg
|
2006
|
0.87
|
56
|
Tpl2 kinase impacts tumor growth and metastasis of clear cell renal cell carcinoma.
|
Mol Cancer Res
|
2013
|
0.87
|
57
|
STAT1 and Nmi are downstream targets of Ets-1 transcription factor in MCF-7 human breast cancer cell.
|
FEBS Lett
|
2005
|
0.86
|
58
|
The progression of gliomas is associated with cancer stem cell phenotype.
|
Oncol Rep
|
2008
|
0.86
|
59
|
Hypoxia-associated protein expression in primary central nervous system diffuse large B-cell lymphoma: does it predict prognosis?
|
Leuk Lymphoma
|
2011
|
0.86
|
60
|
Synergistic therapeutic effects of cytokine-induced killer cells and temozolomide against glioblastoma.
|
Oncol Rep
|
2011
|
0.85
|
61
|
Replacement of microglial cells using Clodronate liposome and bone marrow transplantation in the central nervous system of SOD1(G93A) transgenic mice as an in vivo model of amyotrophic lateral sclerosis.
|
Biochem Biophys Res Commun
|
2012
|
0.85
|
62
|
Ventriculoperitoneal shunt for hydrocephalus caused by central nervous system metastasis.
|
J Neurooncol
|
2011
|
0.85
|
63
|
Inhibition of checkpoint kinase 1 sensitizes lung cancer brain metastases to radiotherapy.
|
Biochem Biophys Res Commun
|
2011
|
0.85
|
64
|
Radiosurgery to palliate symptoms in brain metastases from uterine cervix cancer.
|
Acta Neurochir (Wien)
|
2012
|
0.85
|
65
|
hMSC-mediated concurrent delivery of endostatin and carboxylesterase to mouse xenografts suppresses glioma initiation and recurrence.
|
Mol Ther
|
2011
|
0.85
|
66
|
Multisession Gamma Knife surgery for benign orbital tumors.
|
J Neurosurg
|
2012
|
0.85
|
67
|
Intracranial growing teratoma syndrome mimicking tumor relapse: a diagnostic dilemma.
|
J Neurosurg Pediatr
|
2009
|
0.84
|
68
|
Antiangiogenic agent, thalidomide increases the antitumor effect of single high dose irradiation (gamma knife radiosurgery) in the rat orthotopic glioma model.
|
Oncol Rep
|
2006
|
0.84
|
69
|
Experimental and clinical factors influencing long-term stable in vitro expansion of multipotent neural cells from human adult temporal lobes.
|
Exp Neurol
|
2012
|
0.84
|
70
|
Heterogeneous nuclear ribonucleoprotein C1/C2 controls the metastatic potential of glioblastoma by regulating PDCD4.
|
Mol Cell Biol
|
2012
|
0.84
|
71
|
Prospective identification of cancer stem cells with the surface antigen CD133.
|
Methods Mol Biol
|
2009
|
0.84
|
72
|
Radiotherapy followed by adjuvant temozolomide with or without neoadjuvant ACNU-CDDP chemotherapy in newly diagnosed glioblastomas: a prospective randomized controlled multicenter phase III trial.
|
J Neurooncol
|
2010
|
0.84
|
73
|
Efficacy of endoport-guided endoscopic resection for deep-seated brain lesions.
|
Neurosurg Rev
|
2011
|
0.83
|
74
|
Mutated IDH1 is a favorable prognostic factor for type 2 gliomatosis cerebri.
|
Brain Pathol
|
2011
|
0.83
|
75
|
A practical scoring system to determine whether to proceed with surgical resection in recurrent glioblastoma.
|
Neuro Oncol
|
2013
|
0.83
|
76
|
Combined treatment of tumor-tropic human neural stem cells containing the CD suicide gene effectively targets brain tumors provoking a mild immune response.
|
Oncol Rep
|
2011
|
0.83
|
77
|
Functional neural stem cell isolation from brains of adult mutant SOD1 (SOD1(G93A)) transgenic amyotrophic lateral sclerosis (ALS) mice.
|
Neurol Res
|
2010
|
0.82
|
78
|
The role of radiosurgery in patients with brain metastasis from small cell lung carcinoma.
|
J Korean Neurosurg Soc
|
2011
|
0.82
|
79
|
Preliminary report of multisession gamma knife radiosurgery for benign perioptic lesions: visual outcome in 22 patients.
|
J Korean Neurosurg Soc
|
2008
|
0.82
|
80
|
Impact of maximal safe resection on the clinical outcome of adults with craniopharyngiomas.
|
J Clin Neurosci
|
2012
|
0.82
|
81
|
Optimal treatment of leptomeningeal spread in glioblastoma: analysis of risk factors and outcome.
|
Acta Neurochir (Wien)
|
2015
|
0.82
|
82
|
Radiosensitization of brain metastasis by targeting c-MET.
|
Lab Invest
|
2013
|
0.82
|
83
|
Primary central nervous system lymphoma in Korea: comparison of B- and T-cell lymphomas.
|
Am J Surg Pathol
|
2003
|
0.82
|
84
|
Oral paclitaxel chemotherapy for brain tumors: ideal combination treatment of paclitaxel and P-glycoprotein inhibitor.
|
Oncol Rep
|
2008
|
0.81
|
85
|
Prognosis of non-small cell lung cancer with synchronous brain metastases treated with gamma knife radiosurgery.
|
J Korean Med Sci
|
2006
|
0.81
|
86
|
Identification of prognostic biomarkers for glioblastomas using protein expression profiling.
|
Int J Oncol
|
2011
|
0.81
|
87
|
Prognostic factors of hearing preservation after gamma knife radiosurgery for vestibular schwannoma.
|
J Clin Neurosci
|
2010
|
0.80
|
88
|
Loss of adhesion in the circulation converts amelanotic metastatic melanoma cells to melanotic by inhibition of AKT.
|
Neoplasia
|
2006
|
0.80
|
89
|
Blockade of EGFR signaling promotes glioma stem-like cell invasiveness by abolishing ID3-mediated inhibition of p27(KIP1) and MMP3 expression.
|
Cancer Lett
|
2012
|
0.80
|
90
|
Leukoencephalopathy and disseminated necrotizing leukoencephalopathy following intrathecal methotrexate chemotherapy and radiation therapy for central nerve system lymphoma or leukemia.
|
J Korean Neurosurg Soc
|
2011
|
0.80
|
91
|
Stereotactic device for Gamma Knife radiosurgery in experimental animals: technical note.
|
Stereotact Funct Neurosurg
|
2006
|
0.80
|
92
|
Prognostic significance of tetraspanin CD151 in newly diagnosed glioblastomas.
|
J Surg Oncol
|
2012
|
0.79
|
93
|
Clinicopathologic and genomic features of gliosarcomas.
|
J Neurooncol
|
2012
|
0.79
|
94
|
Synergistic effect and condition of pegylated interferon alpha with paclitaxel on glioblastoma.
|
Int J Oncol
|
2006
|
0.79
|
95
|
Tpl2 induces castration resistant prostate cancer progression and metastasis.
|
Int J Cancer
|
2014
|
0.79
|
96
|
Leptomeningeal seeding in patients with brain metastases treated by gamma knife radiosurgery.
|
J Neurooncol
|
2012
|
0.78
|
97
|
Combined therapy of temozolomide and ZD6474 (vandetanib) effectively reduces glioblastoma tumor volume through anti-angiogenic and anti-proliferative mechanisms.
|
Mol Med Rep
|
2012
|
0.78
|
98
|
Gene silencing of c-Met leads to brain metastasis inhibitory effects.
|
Clin Exp Metastasis
|
2013
|
0.78
|
99
|
Injectable hydroxyapatite cement patch as an on-lay graft for the sellar reconstructions following endoscopic endonasal approach.
|
Acta Neurochir (Wien)
|
2012
|
0.78
|
100
|
Outcome of conventional treatment and prognostic factor in elderly glioblastoma patients.
|
Acta Neurochir (Wien)
|
2014
|
0.78
|
101
|
Olfactory outcomes after endoscopic pituitary surgery with nasoseptal "rescue" flaps: electrocautery versus cold knife.
|
Am J Rhinol Allergy
|
2014
|
0.78
|
102
|
Efficacy of temozolomide as adjuvant chemotherapy after postsurgical radiotherapy alone for glioblastomas.
|
Clin Neurol Neurosurg
|
2009
|
0.78
|
103
|
Risk factors and tumor response associated with hydrocephalus after gamma knife radiosurgery for vestibular schwannoma.
|
Acta Neurochir (Wien)
|
2012
|
0.78
|
104
|
Treatment modalities and outcomes for asymptomatic meningiomas.
|
Acta Neurochir (Wien)
|
2010
|
0.78
|
105
|
Efficacy of postoperative radiotherapy for high grade meningiomas.
|
J Neurooncol
|
2014
|
0.78
|
106
|
Response of brain specific microenvironment to P-glycoprotein inhibitor: an important factor determining therapeutic effect of P-glycoprotein inhibitor on brain metastatic tumors.
|
Int J Oncol
|
2008
|
0.77
|
107
|
Prognostic implications of the DNA damage response pathway in glioblastoma.
|
Oncol Rep
|
2011
|
0.77
|
108
|
The therapeutic efficacy of fractionated radiotherapy and gamma-knife radiosurgery for craniopharyngiomas.
|
J Clin Neurosci
|
2011
|
0.77
|
109
|
Nonconvulsive status epilepticus presenting as epileptic nystagmus in a patient with herpes encephalitis.
|
J Neuroophthalmol
|
2012
|
0.77
|
110
|
Immunohistochemical study on the expression of calcium binding proteins (calbindin-D28k, calretinin, and parvalbumin) in the cerebral cortex and in the hippocampal region of nNOS knock-out(-/-) mice.
|
Anat Cell Biol
|
2011
|
0.77
|
111
|
Anti-angiogenic action of plasma hyaluronan binding protein in human umbilical vein endothelial cells.
|
Int J Oncol
|
2006
|
0.77
|
112
|
TTAC-0001, a human monoclonal antibody targeting VEGFR-2/KDR, blocks tumor angiogenesis.
|
MAbs
|
2015
|
0.77
|
113
|
High-throughput, miniaturized clonogenic analysis of a limiting dilution assay on a micropillar/microwell chip with brain tumor cells.
|
Small
|
2014
|
0.77
|
114
|
Prognostic implication of progression pattern after anti-VEGF bevacizumab treatment for recurrent malignant gliomas.
|
J Neurooncol
|
2015
|
0.76
|
115
|
Impact of adjuvant chemotherapy for gliomatosis cerebri.
|
BMC Cancer
|
2010
|
0.76
|
116
|
The expression of DNA damage checkpoint proteins and prognostic implication in metastatic brain tumors.
|
Oncol Res
|
2011
|
0.76
|
117
|
Antitumor activity of ZD6474 in a metastatic orthotopic brain tumor model.
|
Mol Med Rep
|
2011
|
0.76
|
118
|
Preservation of quality of life by preradiotherapy stereotactic radiosurgery for unresectable glioblastoma multiforme.
|
J Neurosurg
|
2006
|
0.76
|
119
|
Genetically-engineered human neural stem cells with rabbit carboxyl esterase can target CNS lymphoma.
|
Anticancer Res
|
2013
|
0.76
|
120
|
Risk of seizure and its clinical implication in the patients with cerebral metastasis from lung cancer.
|
Acta Neurochir (Wien)
|
2013
|
0.76
|
121
|
Integrative radiogenomic analysis for genomic signatures in glioblastomas presenting leptomeningeal dissemination.
|
Medicine (Baltimore)
|
2016
|
0.75
|
122
|
Treatment outcomes after surgical resection of midline anterior skull base meningiomas at a single center.
|
J Clin Neurosci
|
2012
|
0.75
|
123
|
Outcome of radiosurgery for recurrent malignant gliomas: assessment of treatment response using relative cerebral blood volume.
|
J Neurooncol
|
2014
|
0.75
|
124
|
Basilar artery angulation in association with aging and pontine lacunar infarction: a multicenter observational study.
|
J Atheroscler Thromb
|
2014
|
0.75
|
125
|
Differential impact of whole-brain radiotherapy added to radiosurgery for brain metastases.
|
Int J Radiat Oncol Biol Phys
|
2010
|
0.75
|
126
|
Stereotactic aspiration of intracerebral haematoma: significance of surgical timing and haematoma volume reduction.
|
J Clin Neurosci
|
2003
|
0.75
|
127
|
Communicating hydrocephalus associated with surgery or radiosurgery for vestibular schwannoma.
|
J Clin Neurosci
|
2010
|
0.75
|
128
|
Adenosine potentiates the therapeutic effects of neural stem cells expressing cytosine deaminase against metastatic brain tumors.
|
Oncol Rep
|
2013
|
0.75
|